Announced Mon, 6 Jul · 17:18 IST
Beryl Drugs Files Non-Applicability Certificate Under Reg 57(5) for Q1FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+14.2%1-day move
₹20.71
prior close
₹20.32
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+14.2+11.1+17.7+6.1+3.4+2.5————
Up moveDown movePending
AI summary
Beryl Drugs has submitted a non-applicability certificate under SEBI Regulation 57(5) for the quarter ended 30 June 2026. The company clarified that the regulation does not apply to it as there are no non-convertible securities outstanding for which interest, dividend, or principal payments are due during the quarter.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock price.